TRUE statements regarding halothane is
**Core Concept**
Halothane is a potent inhalational anesthetic agent used for general anesthesia, known for its rapid onset and short duration of action. It undergoes hepatic metabolism, primarily through the cytochrome P450 enzyme system, and has a potential for causing hepatotoxicity.
**Why the Correct Answer is Right**
Halothane undergoes a process called "trifluoroacetylation" where it forms a reactive intermediate that covalently binds to cellular macromolecules, leading to cellular damage and apoptosis. This process is more pronounced in individuals with pre-existing liver disease or those who are re-exposed to halothane after a previous exposure. The enzyme responsible for this metabolism is CYP2E1, which is also involved in the metabolism of other hepatotoxic substances. The risk of hepatotoxicity is increased in patients with pre-existing liver disease, making it a contraindication for their use.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not accurately describe a true statement regarding halothane.
**Option B:** This option is incorrect as it does not describe a characteristic of halothane.
**Option C:** This option is incorrect as it is not a true statement regarding halothane.
**Clinical Pearl / High-Yield Fact**
Halothane is contraindicated in patients with pre-existing liver disease due to its potential for causing hepatotoxicity, and its use should be avoided in such patients.
**Correct Answer:** Not Provided